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Abstract
We report here a new example in which glucocorticoids (GCs) acted in a rapid, nongenomic way. In rat B103 neuroblastoma cells, 5-
hydroxytryptamine (5-HT) was found to evoke an immediate rise in intracellular free calcium concentration ([Ca2 + ]i). Pre-incubation of
B103 cells for 5 min with corticosterone (B) or bovine serum albumin-conjugated corticosterone (B–BSA) concentration-dependently
(10 4–10 8 M) inhibited the peak increments in [Ca2 + ]i. Cortisol and dexamethasone had a similar effect, while deoxycorticosterone and
cholesterol were ineffective. This rapid inhibitory effect of corticosterone could be mimicked by protein kinase C (PKC) activator phorbol
12-myristate 13-acetate (PMA) and abolished completely by PKC inhibitors Ro31-8220 or GF-109203X. Neither pertussis toxin (PTX) nor
nuclear GC receptor (GR) antagonist RU38486 influenced the rapid action of B. Our results suggest that GCs can modulate the 5-HT-induced
Ca2 + response in B103 cells in a membrane-initiated, nongenomic, and PKC-dependent manner. D 2002 Elsevier Science B.V. All rights
reserved.
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1. Introduction
Glucocorticoids (GCs), among other steroid hormones,
have important effects on the developmental organization
and ongoing activities of the nervous system [1]. At the
cellular level, they work in a complex and diverse manner.
In the 1960s, the intracellular GC receptors (GR) were
identified. Binding of GCs with GR leads to the formation
of active nuclear transcription factors that initiate gene
transcription and protein synthesis. The genomic theory
can satisfactorily account for most metabolic and develop-
mental processes caused by GCs with slow onset and an
extended time course. However, it met with difficulties in
explaining the rapid actions of GCs (onset in seconds or
minutes) [2]. There are many such examples in the nervous
system, ranging from the regulation of neuronal excitability
to the modulation of neurotransmitter secretion and uptake
[1,2]. As a complement to the classic genomic theory, a
nongenomic mechanism was suggested for the rapid actions
of GCs, proposing the interaction between GCs and putative
membrane GC receptors (mGRs) [2,3]. To date, several
distinctive membrane proteins have been reported as the
mGRs that mediate specific rapid actions of GCs [4–6].
However, the functional universality of these mGRs has not
yet been tested.
The signal transduction pathways underlying rapid
actions of GCs diversify greatly. Data from different exper-
imental systems show that the diversity occurs at all stages
from membrane receptors, G proteins, second messengers,
and protein kinases to effectors [2,3]. In many instances,
only a single mechanism has been identified for certain
measured responses in a given tissue or cell type, and
therefore it is not easy to compare these results and draw
useful general principles. Thus, it has been suggested that
the task in this research area, at present, should be to collect
enough examples of rapid membrane-initiated actions [3] to
make sense of the organization of the sundry signalings and
their biological meaning.
5-Hydroxytryptamine (5-HT) is a ubiquitous neurotrans-
mitter that plays a pivotal role in physiological functions,
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and has been associated with some neurological and neuro-
psychiatric disorders [7–9]. In preliminary observations, we
found a rapid increase in intracellular free calcium concen-
tration ([Ca2 + ]i) in rat B103 neuroblastoma cells following
5-HT treatment. The Ca2 + response was decreased by the
activation of protein kinase C (PKC). As it is already known
that some of the rapid actions of GCs are PKC-mediated
[10,11], we wonder whether this is the case in B103 cells. In
this report, we first studied the 5-HT-elicited calcium
response in more detail in terms of the signal transduction
pathway, then we demonstrated that the response could be
modified by GCs through a membrane-initiated, nonge-
nomic pathway that was PKC-dependent.
2. Materials and methods
2.1. Materials
5-HT, a-methyl-5-HT, bovine serum albumin-conjugated
corticosterone (B–BSA), cholesterol, clozapine, corticoster-
one (B), cortisol, cyproheptadine, deoxycorticosterone, dex-
amethasone, EGTA, HEPES, ionomycin, MDL-72222,
pluronic F-127, phorbol 12-myristate 13-acetate (PMA),
propranolol, and RU38486 were purchased from Sigma
(St. Louis, MO). Forskolin, GF-109203X, H89, pertussis
toxin (PTX), and Ro31-8220 were obtained from Calbio-
chem-Novabiochem Co. (San Diego, CA). DMEM and L-
glutamine used for cell culture were from Life Technologies
(Gaithersburg, MD). Trypsin was from Amresco (Solon,
OH). Fura-2 AM was purchased from Molecular Probes Inc.
(Eugene, OR). Newborn calf serum was from Evergreen Co.
(Hangzhou, China). All other chemicals used were of ana-
lytical grade.
2.2. Cell culture
B103 rat neuroblastoma cells, a kind gift from Dr. David
Schubert (The Salk Institute, La Jolla, CA) [12], were grown
at 37 jC in DMEM supplemented with 10% newborn calf
serum and 4 mM L-glutamine in a humidified atmosphere of
95% air and 5% CO2. No antibiotic was added to the media.
For [Ca2 + ]i measurements, B103 cells were seeded on glass
coverslips and used in 2–3 days.
2.3. Fura-2 loading
In this study, fluorescent dye fura-2 was used to indicate
the intracellular Ca2 + concentration. The cells on the cover-
slips were loaded in situ at 37 jC for 30–60 min in HEPES-
buffered saline (140 mM NaCl, 5 mM KCl, 1 mM MgCl2,
2.5 mM CaCl2, 11.5 mM glucose, 10 mM HEPES, pH 7.2–
7.4) containing 2 AM fura-2 AM and 0.04% pluronic F-127.
Afterwards, fura-2-loaded cells were rinsed three times with
saline and mounted in a perfusion chamber for immediate
[Ca2 + ]i determination. Alternatively, they were kept in the
dark at room temperature for up to 2 h. Fura-2 loading was
uniform over the cytoplasm, and compartmentalization of
the dye was seldom observed.
2.4. [Ca2+]i determination
Measurement of intracellular Ca2 + concentration was
carried out by the dual-wavelength fluorescence method as
described previously [13] with some modifications. Briefly,
fura-2-loaded cells were mounted in a perfusion chamber
and placed on the stage of an inverted microscope (IX70,
Olympus). Light emitted from a 75-W xenon arc lamp
(AH2-RX, Olympus) passed through an excitation filter
set (Chroma) to generate ultraviolet monochromatic waves
of 340 and 380 nm. With the aid of a computerized filter
wheel (Lambda 10-2, Sutter Instruments), the cells in the
chamber were alternately exposed to the two waves through
an Olympus UApo objective (40 /340/0.90 N.A.). The
resulting fluorescent emission from the Ca2 + -sensitive dye
was collected through a 510-nm-long pass filter (Chroma)
with a cooled charge-coupled device (CCD) camera (Micro-
Max 5 MHz system, Princeton Instruments). All image
acquisition was computer-controlled by MetaFluor Imaging
program (v.4.01, Universal Imaging). Images were acquired
at 3-s intervals to reduce photobleaching. All measurements
were made at 22–25 jC.
Images acquired were corrected for background fluores-
cence and shading across the field of view before calculat-
ing the ratio of the fluorescent emission intensities at each
excitation wavelength (340/380 nm). Conversion of the ratio
to [Ca2 + ]i was carried out using the equation: [Ca
2 + ]i =Kd [(RRmin)/(RmaxR)] (Fmin/380Fmax380), where Rmax
and Rmin are the maximum and minimum ratio obtained by
the addition of ionomycin (10 Amoll  1) and EGTA (10
mmoll  1), respectively; Fmin/380Fmax380 is the ratio of
Ca2 + -free and Ca2 + -saturated fluorescence signals at the
excitation wavelength of 380 nm; and Kd is the dissociation
constant of the fura-2/Ca2 + complex (224 nmoll 1). R is
the experimental ratio value.
2.5. Perfusion chamber and drug applications
The custom-built chamber, bottomed with a cover
glass, was continuously perfused with HEPES-buffered
saline during measurements. The perfusion rate was set
at 2 ml/min to aid drug removal. All drugs were diluted in
saline from their stock solutions immediately before
experiments, and applied directly to the cells using a
computer/manual operated seven-barrel local superfusion
system for desired lengths of time. The tip (100-Am inside
diameter) of the outlet was placed approximately 200 Am
away from the cells, and the gravity force was adjusted
to achieve rapid drug application while avoiding any
mechanical disturbance of the cells. The time delay for
arrival of drugs at the cells was less than 100 ms (data not
shown).
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2.6. Data analysis
[Ca2 + ]i values were expressed as meansF S.E. Statisti-
cal analysis was performed using Student’s t test or analysis
of variance (ANOVA) depending on the data types. A P
value of < 0.05 was considered significant.
3. Results
3.1. 5-HT-induced [Ca2+]i increase
In B103 cells, 10 AM 5-HT induced a biphasic increase
in [Ca2 + ]i as measured by fura-2 fluorescence ratiometric
imaging (n = 270 cells) (Fig. 1A). The response was char-
acterized by a rapid spike followed by a decreased platform.
The sustained phase could last several minutes until the
agonist was removed. The peak [Ca2 + ]i increment induced
by 10 AM 5-HT was insensitive to extracellular Ca2 +
depletion, while the sustained phase disappeared in the
same condition (n = 90 cells) (Fig. 1A). These results
suggest that Ca2 + release from intracellular stores contrib-
utes to the initial [Ca2 + ]i spike, and the latter plateau
requires extracellular Ca2 + influx.
In order to minimize the effect of homologous desen-
sitization, we generally exposed the cells to the agonist
for no more than 30 s. Under this condition, the peak
[Ca2 + ]i increments after repetitive stimulations were
almost unchanged (n = 61 cells) (Fig. 1B). This nature
of the reaction facilitated the subsequent experiments and
rendered the results obtained by repetitive treatments of a
cell readily comparable. Only peak increments were
analyzed in the study. The enhancement of [Ca2 + ]i by
5-HT observed in B103 cells was saturable and concen-
tration dependent, with an EC50 value of 0.97F 0.02 AM
(Fig. 1C).
Pretreatment with 5 AM cyproheptadine, a 5-HT2 recep-
tor antagonist, completely blocked the [Ca2 + ]i increase
elicited by 10 AM 5-HT (n = 170 cells) (Fig. 2A). Antago-
nists for other 5-HT receptors, such as propranolol (5-HT1),
MDL-72222 (5-HT3), and clozapine (5-HT6/5-HT7), had no
effect (data not shown). Furthermore, upon the addition of
the selective 5-HT2 receptor agonist a-methyl-5-HT (10
AM), a very similar [Ca2 + ]i increase could be detected
(n = 43 cells) (Fig. 2B). Taken together, these results suggest
an involvement of 5-HT2 receptor in 5-HT-induced [Ca
2 + ]i
increase in B103 cells.
The possible involvement of PKC and cAMP-depend-
ent protein kinase (PKA) in the response were further
examined. Pretreatment with 1 AM forskolin or 20 AM
H89 had no effect on both the basal and stimulated
[Ca2 + ]i levels (data not shown). On the contrary, exposure
to PKC activator PMA (1 AM) for 3 min before 5-HT
application significantly decreased the [Ca2 + ]i elevations
(Fig. 4), while PMA alone had no effect on the basal
[Ca2 + ]i level (data not shown). PKC inhibitors Ro31-8220
(0.5 AM) or GF-109203X (0.5 AM) preserved the Ca2 +
response if they were applied before PMA (data not
shown).
Fig. 1. The [Ca2 + ]i increase induced by 5-HT in B103 cells. (A) An
increase in [Ca2 + ]i was observed in response to 10 AM 5-HT. Traces from a
representative cell are shown and superimposed for ease of comparison
(continuous trace: measurements done in HEPES-buffered saline, dotted
trace: extracellular Ca2 + depleted). The horizontal bar represents drug
application. (B) Repetitive treatments with 5-HT did not influence the peak
increments if each application lasted only 30 s and the interval between
stimulations was 3–4 min. (C) 5-HT-induced [Ca2 + ]i peak increments
(D[Ca2 + ]i) as a function of 5-HT concentrations. Each point represents the
average of three determinations.
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3.2. Rapid effects of GCs on 5-HT-induced [Ca2+]i increase
The 5-HT-induced [Ca2 + ]i increase was significantly
decreased if B103 cells had been pretreated with B (10  6
M) for 5 min (n = 450 cells) (Fig. 3A and B). The original
Ca2 + response could recover 5–10 min after B was washed
out (data not shown). Other GCs or analogs, such as cortisol
and dexamethasone, were also tested and shown to be
effective using the same experimental protocol (n = 110
and 85 cells, respectively). However, deoxycorticosterone
and cholesterol had no influence (n = 53 and 69 cells,
respectively) (Fig. 3B). The rapid effects of B and B–
BSA were concentration-dependent (10  4–10 8 M). B–
BSAwas found here as effective as B (Fig. 3C), while BSA
itself had no effect on either basal or stimulated [Ca2 + ]i
levels (data not shown).
To further elucidate the rapid action of B, we studied the
effect of RU38486 (a GR antagonist) on the response.
Pretreatment with RU38486 (10  6 M) for 30 min did not
influence the inhibitory effect of B (10  6 M) (Fig. 4). Thus,
the findings above imply that the action of B in B103 cells is
initiated at the plasma membrane and may not involve the
nuclear receptors.
Fig. 3. Effects of glucocorticoids on 5-HT-induced [Ca2 + ]i increase in
B103 cells. (A) The [Ca2 + ]i increase elicited by 10 AM 5-HT in HEPES-
buffered saline was measured after a 5-min pre-incubation with or without 1
AM B. Representative traces from a single cell are presented (continuous
trace: 5-HT only, dotted trace: B pretreated). (B) The [Ca2 + ]i increases
elicited by 10 AM 5-HT were measured after a 5-min pre-incubation with
cortisol (F), dexamethasone (Dex), deoxycorticosterone (Doc), and
cholesterol (Cho), respectively. All steroids were 1 AM in concentration.
*P < 0.05 versus control (10 AM 5-HT only). Each column represents the
average of three determinations. (C) Dose– response relationships of the B
and B-BSA induced inhibition. *P < 0.05 versus control (10 AM 5-HT
only). Each point represents the average of three to four determinations.
Fig. 2. The [Ca2 + ]i increase was mediated by 5-HT2 receptors. (A)
Exposure of cells to a 5-HT2 receptor antagonist, cyproheptadine (5 AM),
for 2 min before 5-HT (10 AM) completely abrogated the [Ca2 + ]i increase
(dotted trace). (B) The 5-HT2 receptor agonist a-methyl 5-HT (10 AM)
induced a transient [Ca2 + ]i increase in B103 cells, which was similar in
amplitude to that evoked by 10 AM 5-HT.
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It has been reported that some of the rapid, nongenomic
actions of GCs involve PTX-sensitive G-protein subtypes
[10,11,14]. The effect of PTX in our model was also
examined. B103 cells were incubated in normal culture
medium for 24 h with 100 ng/ml PTX, and then [Ca2 + ]i
was measured in HEPES-buffered saline. As shown in Fig.
4, PTX did not influence the inhibitory effect of B (10  6
M), implying that Gi/o-type G protein is not involved in the
signaling pathway mediating the rapid action of B.
Our previous data showed that 5-HT-evoked [Ca2 + ]i
increase was negatively modulated by PKC in B103 cells.
Therefore, we examined whether PKC-related signaling
pathways were involved in the B-induced inhibition. PKC
inhibitors Ro31-8220 (0.5 AM) or GF-109203X (0.5 AM),
when applied 20 or 5 min, respectively, before B, com-
pletely abrogated the inhibitory effect of B (1 AM), while
H89 (20 AM) had little influence (Fig. 4). These results
suggest that B-induced inhibition is mediated by PKC
activation that can be mimicked by PMA. Neither PKC
inhibitors changed the basal [Ca2 + ]i level in B103 cells
(data not shown).
4. Discussion
In this study, we first observed the effect of 5-HT on
[Ca2 + ]i levels in B103 cells. Further analyses indicated that
protein kinase C participated in modulating the 5-HT-
induced [Ca2 + ]i increase. Finally, a rapid membrane-initi-
ated and nongenomic action of GCs was found in the same
model.
Several 5-HT receptor subtypes, such as 5-HT1A, 5-HT1B,
5-HT1D, 5-HT1F, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, and 5-
HT7A, are linked to increases in [Ca
2 + ]i via different
signaling pathways [15,16]. In B103 cells, the effect of 5-
HTwas only blocked by 5-HT2 antagonist, while antagonists
against 5-HT1, 5-HT3, and 5-HT6/7 receptors failed to alter
[Ca2 + ]i levels. Furthermore, selective 5-HT2 agonist a-
methyl-5-HT evoked a similar [Ca2 + ]i transient. Therefore,
activation of 5-HT2 receptors was likely to be respon-
sible for the [Ca2 + ]i increase in B103 cells. It is interesting
to note that clozapine is able to block 5-HT2A/2C receptors in
certain experimental models [17]. We do not know for the
moment the reason why clozapine did not influence the
calcium response in B103 cells. There are two possibilities:
(1) the receptor on B103 cells is of 5-HT2B subtype which is
insensitive to clozapine treatment [17]; (2) clozapine did not
block 5-HT receptors under the experimental condition we
adopted.
5-HT2 receptors are documented to couple phospholipase
C via Gq/11 proteins [16,18]. In our experiments, pretreat-
ment with PTX had no effect on 5-HT-induced [Ca2 + ]i
increase, suggesting that Gi/o protein was not involved. But
whether Gq/11 protein was the G-protein that led to the Ca
2 +
response is still unclear and deserves further investigation.
Several kinases have been shown to modulate the 5-HT-
induced [Ca2 + ]i increases, including PKC, PKG, and tyro-
sine kinase [19–21]. In the present study, the role of PKA in
the signaling pathway was excluded as manipulations to
regulate PKA function failed to affect the Ca2 + response.
On the other hand, the regulatory effect of PKC activation
was pharmacologically substantiated.
Pre-incubation with B rapidly inhibited the 5-HT-induced
[Ca2 + ]i increase in B103 cells in a concentration-dependent
manner. The minimum effective dose was 10 8 M, which
falls below the peak free B concentration (7.5 10 7 M) in
Fig. 4. Modulation of the 5-HT-induced [Ca2 + ]i increase in B103 cells. Experimental details are described in the relative parts of the text. The abbreviations
first used in the figure are: RU, RU38486; Ro, Ro31-8220; GF, GF109203X. Each column represents the average of three to four determinations. *P < 0.05
versus control (10 AM 5-HT only); # P > 0.05 versus B + 5-HT group.
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rat serum during stress [22]. The pre-incubation time for B
adopted in most of our experiments was 5 min. However, a 3-
min pretreatment was found enough for B to take effect (data
not shown). The very short latency is consistent with the
criteria to define a rapid effect of steroid hormones [1]. In
addition, the rapid action was insensitive to treatment with
nuclear receptor antagonist.
Being large and predominantly hydrophilic molecules,
steroid–BSA conjugates are thought to be membrane-
impermeable within 30 min [23]. However, they are bio-
logically active and can mimic the actions of free steroids
[24]. In our study, B–BSAwas found effective in inhibiting
5-HT-induced [Ca2 + ]i increase, implying that B might act
on a target in the plasma membrane, which then transduced
a signal into the cells and resulted in detectable effects.
Although several membrane proteins have been identified as
the mGRs, the identity of the membrane target in B103 cells
needs to be elucidated further. The potency of B–BSA in
this experimental model is almost the same as that of B.
Previous work in our lab has revealed that both B and B–
BSA activate PKC in PC12 cells, but the dose–response
curve of the latter shifts rightward (i.e. with lower potency)
[10]. The reason for the difference is so far unclear.
It is well known that a functionally active heterotrimeric
G protein includes an a, h, and g subunit. Up to now,
approximately 17 different a, four different h, and seven
different g subunits have been identified, and a great num-
ber of heterotrimers composed of distinct a, h, and g
subunits may exist and be involved in signal transduction
pathways [25]. In this study, we tested the G protein spe-
cies according to a subunits. PTX-sensitive Gi/o protein is
the major type of G proteins involved in the rapid non-
genomic effects of GCs [2,10,11,14]. However, the partic-
ipation of this protein in the signaling pathway was not
substantiated in B103 cells. Further work needs to be done
to reveal if multiple types of G proteins, depending upon
the tissue or cell type, can mediate the rapid inhibitory ac-
tion of GCs.
Although several protein kinases are known to be acti-
vated by brief treatment with GCs, the protein kinase
involved in rapid GCs actions we found in our lab, so far,
is exclusively PKC [2,10,11,26]. The activation of PKC by
treatment with GCs has been not only pharmacologically
demonstrated, but also directly measured [10,11,26]. These
studies suggest that PKC activation by brief treatment with
GCs is a widespread phenomenon. The notion is now
further substantiated by the above-described results in
B103 cells. As there are copious downstream targets for
PKC, many cellular functions can be modulated by mem-
brane-initiated actions of GCs.
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